132 related articles for article (PubMed ID: 12378828)
1. [Follow-up of monoclonal gammopathy of undetermined significance in a population of 51 patients older than 70 years ].
Decaux O; Cazalets-Lacoste C; Cador-Rousseau B; Laurat E; Sebillot M; Bracq J; Jego P; Leblay R; Grosbois B
Rev Med Interne; 2002 Sep; 23(9):751-8. PubMed ID: 12378828
[TBL] [Abstract][Full Text] [Related]
2. Prognostic factors for malignant transformation in monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
Cesana C; Klersy C; Barbarano L; Nosari AM; Crugnola M; Pungolino E; Gargantini L; Granata S; Valentini M; Morra E
J Clin Oncol; 2002 Mar; 20(6):1625-34. PubMed ID: 11896113
[TBL] [Abstract][Full Text] [Related]
3. A long-term study of prognosis in monoclonal gammopathy of undetermined significance.
Kyle RA; Therneau TM; Rajkumar SV; Offord JR; Larson DR; Plevak MF; Melton LJ
N Engl J Med; 2002 Feb; 346(8):564-9. PubMed ID: 11856795
[TBL] [Abstract][Full Text] [Related]
4. Long-term follow-up of IgM monoclonal gammopathy of undetermined significance.
Kyle RA; Therneau TM; Rajkumar SV; Remstein ED; Offord JR; Larson DR; Plevak MF; Melton LJ
Blood; 2003 Nov; 102(10):3759-64. PubMed ID: 12881316
[TBL] [Abstract][Full Text] [Related]
5. Role of different hematologic variables in defining the risk of malignant transformation in monoclonal gammopathy.
Baldini L; Guffanti A; Cesana BM; Colombi M; Chiorboli O; Damilano I; Maiolo AT
Blood; 1996 Feb; 87(3):912-8. PubMed ID: 8562962
[TBL] [Abstract][Full Text] [Related]
6. Malignant transformation in IgM monoclonal gammopathy of undetermined significance.
Montoto S; Rozman M; Rosiñol L; Nadal E; Giné E; Aymerich M; Ferrer A; Esteve J; Bosch F; López-Guillermo A; Bladé J; Montserrat E
Semin Oncol; 2003 Apr; 30(2):178-81. PubMed ID: 12720132
[TBL] [Abstract][Full Text] [Related]
7. Malignant transformation of monoclonal gammopathy of undetermined significance among out-patients of a community hospital in southeastern Netherlands.
van de Poel MH; Coebergh JW; Hillen HF
Br J Haematol; 1995 Sep; 91(1):121-5. PubMed ID: 7577618
[TBL] [Abstract][Full Text] [Related]
8. Blood clonal B-cell excess in patients with monoclonal gammopathy of undetermined significance (MGUS): association with malignant transformation.
Isaksson E; Björkholm M; Holm G; Johansson B; Nilsson B; Mellstedt H; Osterborg A
Br J Haematol; 1996 Jan; 92(1):71-6. PubMed ID: 8562414
[TBL] [Abstract][Full Text] [Related]
9. Monoclonal gammopathy of undetermined significance (MGUS)-31 year follow up of a community study.
Colls BM
Aust N Z J Med; 1999 Aug; 29(4):500-4. PubMed ID: 10868527
[TBL] [Abstract][Full Text] [Related]
10. Malignant transformation and life expectancy in monoclonal gammopathy of undetermined significance.
Blade J; Lopez-Guillermo A; Rozman C; Cervantes F; Salgado C; Aguilar JL; Vives-Corrons JL; Montserrat E
Br J Haematol; 1992 Jul; 81(3):391-4. PubMed ID: 1390212
[TBL] [Abstract][Full Text] [Related]
11. [Malignant transformation of monoclonal gammopathy of undetermined significance].
Decaux O; Avet-Loiseau H; Grosbois B
Presse Med; 2007 Dec; 36(12 Pt 3):1985-96. PubMed ID: 17509811
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal gammopathy of undetermined significance.
Kyle RA
Blood Rev; 1994 Sep; 8(3):135-41. PubMed ID: 7819815
[TBL] [Abstract][Full Text] [Related]
13. Long-term follow-up of patients with monoclonal gammopathy of undetermined significance after kidney transplantation.
Naina HV; Harris S; Dispenzieri A; Cosio FG; Habermann TM; Stegall MD; Dean PG; Prieto M; Kyle RA; Rajkumar SV; Leung N
Am J Nephrol; 2012; 35(4):365-71. PubMed ID: 22473253
[TBL] [Abstract][Full Text] [Related]
14. Long-term follow-up of 241 patients with monoclonal gammopathy of undetermined significance: the original Mayo Clinic series 25 years later.
Kyle RA; Therneau TM; Rajkumar SV; Larson DR; Plevak MF; Melton LJ
Mayo Clin Proc; 2004 Jul; 79(7):859-66. PubMed ID: 15244381
[TBL] [Abstract][Full Text] [Related]
15. Cancer risk in patients with monoclonal gammopathy of undetermined significance.
Gregersen H; Mellemkjaer L; Salling Ibsen J; Sørensen HT; Olsen JH; Pedersen JO; Dahlerup JF
Am J Hematol; 2000 Jan; 63(1):1-6. PubMed ID: 10602159
[TBL] [Abstract][Full Text] [Related]
16. Incidence and evolution of monoclonal gammopathy of undetermined significance (MGUS) in Greece.
Anagnostopoulos A; Evangelopoulou A; Sotou D; Gika D; Mitsibounas D; Dimopoulos MA
Ann Hematol; 2002 Jul; 81(7):357-61. PubMed ID: 12185503
[TBL] [Abstract][Full Text] [Related]
17. Risk of malignant transformation in patients with monoclonal gammopathy of undetermined significance.
Pasqualetti P; Casale R
Biomed Pharmacother; 1997; 51(2):74-8. PubMed ID: 9161471
[TBL] [Abstract][Full Text] [Related]
18. [Epidemiology of monoclonal gammopathy in a general hospital and a university internal medicine department].
Decaux O; Rodon P; Ruelland A; Estepa L; Leblay R; Grosbois B
Rev Med Interne; 2007 Oct; 28(10):670-6. PubMed ID: 17566610
[TBL] [Abstract][Full Text] [Related]
19. [Monoclonal gammopathy of undetermined significance and asymptomatic multiple myelom in the year 2014 ].
Adam Z; Krejčí M; Pour L; Sevčíková E; Křivanová A; Rehák Z; Koukalová R; Cermáková Z; Vaníček J; Sevčíková S
Vnitr Lek; 2014 Oct; 60(10):861-79. PubMed ID: 25382009
[TBL] [Abstract][Full Text] [Related]
20. [Monoclonal gammopathies of undetermined significance and their progression over time. Retrospective study of 190 patients].
Decaux O; Cuggia M; Ruelland A; Cazalets C; Cador B; Jego P; Grosbois B
Presse Med; 2006; 35(7-8):1143-50. PubMed ID: 16840890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]